Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Credit agrmnt [a]
CC transcript
Asset disposition
Acq. announced
Director departure
Appointed COO
Orthofix Medical Inc. (OFIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Investor presentation, Quarterly results
Docs: "Orthofix Reports Second Quarter 2023 Results and Raises Revenue and Adjusted EBITDA Guidance • Net sales of $187.0 million, an increase of 58% on a reported basis and 7% on a pro forma constant currency basis over prior year • Bone Growth Therapies growth of 10%, marking two consecutive quarters with double-digit net sales increases, with growth coming from both spine and fracture commercial channels • U.S. spinal implants, biologics, and enabling technologies sales up 7% over prior year on a pro forma basis, driven by new distribution and product innovation • Global Orthopedics net sales increase of 6% on a reported basis and 5% on a constant currency basis over prior year • Announced full commercial launch of the following products: o WaveForm® A interb...",
"Corporate Investor Deck August 2023 Forward Looking Statements This"
05/26/2023 4 Kenny Kevin J. (President of Global Spine) has filed a Form 4 on Orthofix Medical Inc.
Txns: Sold 4,367 shares @ $19, valued at $83k
Sold 3,876 shares @ $19, valued at $73.6k
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Orthofix Reports First Quarter 2023 Results • Net sales of $175.2 million, an increase of 65% on a reported basis and 12% on a pro forma constant currency basis over prior year • Bone Growth Therapies growth of 14%, with growth coming from both spine and fracture commercial channels • U.S. spinal implant sales up 18% over prior year on a pro forma basis, driven by new distribution and product innovation • Continued double-digit growth in Global Orthopedics over prior year on a constant currency basis • Announced the full commercial launch of the Lattus™ Lateral Access System and the Fathom™ Pedicle-Based Retractor System, which addresses an estimated $1.8 billion market related to minimally invasive spine procedures"
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2023 4 Kenny Kevin J. (President of Global Spine) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 1,956 shares @ $16.75, valued at $32.8k
Granted 7,449 shares @ $0
Granted 5,959 options to buy @ $0
Granted 17,061 options to buy @ $16.78, valued at $286.3k
04/05/2023 4 Maniar Shweta (Director) has filed a Form 4 on Orthofix Medical Inc.
Txns: Sold 4,262 shares @ $17.75, valued at $75.7k
04/05/2023 4 Elting Kimberley A. (President, Global Orthopedics) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 2,385 shares @ $16.75, valued at $39.9k
04/05/2023 4 Serbousek Jon Carl (Executive Chairman) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 6,141 shares @ $16.75, valued at $102.9k
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/06/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 8-K Quarterly results
Docs: "Orthofix Medical Reports Orthofix and SeaSpine Fourth Quarter and Full-Year 2022 Results LEWISVILLE, Texas — March 6, 2023 — The merger of Orthofix Medical Inc. and SeaSpine Holdings Corporation became effective as of January 5, 2023. This news release includes the financial results of stand-alone Orthofix and stand-alone SeaSpine for the fourth quarter and full year ended December 31, 2022. As such, these financial results do not include any potential accounting adjustments the merger may have on future net sales or operating results. Orthofix Fourth Quarter Highlights • Net sales of $122.2 million, a decrease of 2% on a reported basis and flat on a constant currency basis over prior year • Bone Growth Therapies net sales growth of approximately 3%, driven by the commercial ..."
03/02/2023 4 Bostjancic John J. (CFO) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 3,783 shares @ $30.6, valued at $115.8k
03/02/2023 4 Valentine Keith (President & CEO) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 16,290 shares @ $20.6, valued at $335.6k
03/02/2023 4 Keran Patrick L (Chief Legal Officer) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 3,792 shares @ $20.6, valued at $78.1k
02/09/2023 4/A BURZIK CATHERINE M (Director) has filed a Form 4 on Orthofix Medical Inc.
Txns: Granted 14,354 shares @ $0
02/09/2023 4/A Hinrichs James F. (Director) has filed a Form 4 on Orthofix Medical Inc.
Txns: Granted 14,354 shares @ $0
02/09/2023 4/A Paolucci Michael E (Director) has filed a Form 4 on Orthofix Medical Inc.
Txns: Granted 14,354 shares @ $0
02/09/2023 4/A HENNEMAN JOHN B III (Director) has filed a Form 4 on Orthofix Medical Inc.
Txns: Granted 14,354 shares @ $0
02/09/2023 4/A ESSIG STUART (Director) has filed a Form 4 on Orthofix Medical Inc.
Txns: Granted 14,354 shares @ $0
02/09/2023 4/A Maniar Shweta (Director) has filed a Form 4 on Orthofix Medical Inc.
Txns: Granted 14,354 shares @ $0
02/09/2023 4/A Hannon Jason (Director) has filed a Form 4 on Orthofix Medical Inc.
Txns: Granted 14,354 shares @ $0
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 7.1% stake in Orthofix Medical Inc.
02/03/2023 4 Kenny Kevin J. (President of Global Spine) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 2,287 shares @ $21.54, valued at $49.3k
02/03/2023 4 Elting Kimberley A. (President, Global Orthopedics) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 2,015 shares @ $21.54, valued at $43.4k
02/03/2023 4 Serbousek Jon Carl (Executive Chairman) has filed a Form 4 on Orthofix Medical Inc.
Txns: Paid exercise price by delivering 5,142 shares @ $21.54, valued at $110.8k
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2023 4/A Kenny Kevin J. (President of Global Spine) has filed a Form 4 on Orthofix Medical Inc.
Txns: Acquired 832 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy